Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alterity Therapeutics Limited

3.97
+0.14003.66%
Pre-market: 3.950.0700+1.80%08:00 EDT
Volume:7.73K
Turnover:29.75K
Market Cap:44.05M
PE:-2.70
High:3.98
Open:3.73
Low:3.72
Close:3.83
Loading ...

Alterity Therapeutics Initiated at Buy by Maxim Group

Dow Jones
·
13 Dec 2024

Alterity Therapeutics completes last patient visit in ATH434-201 trial

TIPRANKS
·
04 Dec 2024

Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy

GlobeNewswire
·
04 Dec 2024

Alterity Therapeutics appoints Abby Macnish Niven as secretary

TIPRANKS
·
19 Nov 2024

Alterity Therapeutics Appoints Abby Macnish Niven as Company Secretary

GlobeNewswire
·
19 Nov 2024

Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434

GlobeNewswire
·
06 Nov 2024

Appendix 4C – Q1 FY25 Quarterly Cash Flow Report

GlobeNewswire
·
31 Oct 2024

Alterity Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit on 17 October 2024

GlobeNewswire
·
14 Oct 2024

Alterity Therapeutics Announces Presentation of New Data Describing Neuroprotection of ATH434 at Neuroscience Meeting

GlobeNewswire
·
11 Oct 2024

Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®

GlobeNewswire
·
02 Oct 2024

Alterity Therapeutics Appoints Abby Niven as CFO

MT Newswires Live
·
30 Sep 2024

Press Release: Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer

Dow Jones
·
30 Sep 2024

Alterity Therapeutics to Deliver Multiple Oral and Poster Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®

GlobeNewswire
·
23 Sep 2024

Alterity Therapeutics Directors’ Holdings Change

TIPRANKS
·
20 Sep 2024